Viewing a single comment thread. View all comments

KetosisMD t1_j7i14jt wrote

Reply to comment by burtzev in Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study by burtzev

That’s nuts.

I can’t believe anyone prescribed dangerous placebos.

It’s hard to know what is more broken the FDA or Healthcare

Edit

> 1.5 million treated

No, 1.5 million would be eligible. CMS denied coverage to anyone who isn’t in a trial.

This is good news. I was hoping CMS would pass on this drug and they did.

8

burtzev OP t1_j7i8181 wrote

I believe you are right and that I misread the NYT article.

3

Xinlitik t1_j7ilsea wrote

Why is CMS paying for trial drugs? I thought pharma companies paid for trials- isnt that their excuse for price gouging after the trial is done?

1

KetosisMD t1_j7im6t0 wrote

You’d think !

The trials will fail. All these new Alzheimer’s drugs are garbage.

2

---LJY--- t1_j7knjo2 wrote

Any promising ones?

1

KetosisMD t1_j7lcj13 wrote

Absolutely zero.

it’s all prevention:

Everything that’s good for the heart is good for the brain.

1